The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $478,309 in first-year total cost, median $44,892.
Most frequent study sections
- Special Emphasis Panel[ZRG1 F01A-F (20)]2
- Special Emphasis Panel[ZRG1 F03B-L (20)]2
- Special Emphasis Panel[ZRG1 F18-E (20)]2
- Special Emphasis Panel[ZRG1 F01A-V (20)]1
- Special Emphasis Panel[ZRG1 F03A-T (20)]1
Most frequent institutions
- UNIVERSITY OF CALIFORNIA AT DAVIS2
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
- ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
- NORTHWESTERN UNIVERSITY AT CHICAGO1
- UNIVERSITY OF MIAMI SCHOOL OF MEDICINE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | A multimodal examination of Alzheimer's disease pathology and synaptic loss1F31AG087651-01A1 | YANG, KAO LEE | UNIVERSITY OF WISCONSIN-MADISON, WI | $40,679 | ZRG1 |
| 2024 | Astrocytic Na/H exchanger in AD astrogliosis1F31AG084260-01A1 | COLLIER, JENELLE MONET | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $48,974 | ZRG1 |
| 2024 | The Influence of Admixture on Biological Aging in the Context of Alzheimer’s Disease1F31AG090006-01 | CRUZ GONZALEZ, SEBASTIAN | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $45,618 | ZRG1 |
| 2024 | Combining Chemical Biology and Machine Learning to Generate Reproducible Amyloid Fibrils1F31AG090063-01 | PEREZ, RYANN MICHAEL | UNIVERSITY OF PENNSYLVANIA, PA | $45,304 | ZRG1 |
| 2024 | Evaluating social and clinical risk factors for the progression from Mild CognitiveImpairment to Alzheimer’s Disease and Related Dementias using Real World ClinicalData1F31AG085938-01 | LIZARRAGA, SILVIA MIRAMONTES | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $44,892 | ZRG1 |
| 2024 | Lifecourse Residential Segregation, Ethnic Enclaves and Risk and Resilience to ADRD in Diverse Cohorts1F31AG085937-01 | LOR, YI | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $41,568 | ZRG1 |
| 2023 | 17 alpha-estradiol as a potential protective therapeutic against development of Alzheimer's disease1F31AG084279-01 | MCGILL, CASSANDRA JOAN | UNIVERSITY OF SOUTHERN CALIFORNIA, CA | $47,694 | ZRG1 |
| 2023 | Examining the genetic regulation of A-to-I editing and mediation of Alzheimer's disease1F31AG084223-01 | CUDDLESTON, WINSTON HIRSCHLER | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $47,534 | ZRG1 |
| 2023 | Evaluating Mechanisms Underlying Resistance in Alzheimer’s Disease1F31AG077721-01A1 | DALLMEIER, JULIAN DIETER | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL | $34,499 | ZRG1 |
| 2022 | Antemortem White Matter Integrity Quantification from DTI and Relationship with Postmortem TDP-431F31AG079630-01 | HEYWOOD, ASHLEY | NORTHWESTERN UNIVERSITY AT CHICAGO, IL | $42,385 | ZRG1 |
| 2022 | The Role of Apolipoprotein E4 in Neuronal Insulin Resistance and Alzheimer's Disease1F31AG079625-01 | GARCIA, CHASE A | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $39,162 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.